Godsey & Gibb Inc’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-195
Closed -$2.07K 405
2024
Q1
$2.07K Hold
195
﹤0.01% 345
2023
Q4
$1.56K Hold
195
﹤0.01% 331
2023
Q3
$1.6K Hold
195
﹤0.01% 311
2023
Q2
$1.56K Hold
195
﹤0.01% 345
2023
Q1
$1.58K Buy
+195
New +$1.57K ﹤0.01% 308
2022
Q4
Sell
-195
Closed -$1K 310
2022
Q3
$1K Hold
195
﹤0.01% 80
2022
Q2
$2K Buy
+195
New +$2.73K ﹤0.01% 94

Other funds holding BHC

Godsey & Gibb Inc's BHC Position: Q2 2024 in Review

Godsey & Gibb Inc sold out of Bausch Health (BHC) in Q2 2024, closing a stake of 195 shares — an estimated $2.07K sold.

Godsey & Gibb Inc first reported a position in BHC in Q2 2022 and held it in 7 quarters. The position peaked at $2.07K in Q1 2024. 234 funds tracked by Wall St. Rank hold BHC as of Q2 2024.

  • Godsey & Gibb Inc reported no remaining Bausch Health position as of Q2 2024 after selling out during the quarter.
  • Godsey & Gibb Inc sold 195 Bausch Health shares in Q2 2024, an estimated $2.07K.
  • Godsey & Gibb Inc first reported a position in Bausch Health in Q2 2022 and held it in 7 quarters.
  • Godsey & Gibb Inc's Bausch Health position peaked at $2.07K in Q1 2024.
  • 234 funds tracked by Wall St. Rank held Bausch Health as of Q2 2024.

Based on Godsey & Gibb Inc's 13F filing for Q2 2024, filed 23 Jul 2024.